Error: Could not add to watchlist. X

Aradigm Corp

+ Watchlist
AQGA:GR
Ticker Delisted
EUR
Volume
0
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-
Market Cap (EUR)
-
Shares Outstanding
-
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Specialty Pharma

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
Aradigm Corporation develops novel pulmonary drug delivery systems. The Company's systems are designed to enhance the delivery and effectiveness of a number of existing and development stage drugs and reduce the need for injectable drug therapy. Aradigm's principal product development programs are based on its AERx pulmonary drug delivery system.
ADDRESS
3929 Point Eden Way
Hayward, CA 94545
United States
PHONE
1-510-265-9000
  • Igor Gonda
    President/CEO
  • Juergen K Froehlich
    Chief Medical Officer
  • Nancy E Pecota
    VP:Finance/CFO/Secretary
  • Robert A Reed
    VP:Regulatory
Show More